Expression of tissue factor and initiation of clotting by human platelets and monocytes after incubation with porcine endothelial cells.
OBJECTIVE
Intravascular thrombosis remains a major barrier to successful pig-to-primate xenotransplantation. However, the precise factors initiating thrombosis are unknown. In this study, we investigated the contribution of recipient platelets and monocytes.


METHODS
Primary pig aortic endothelial cells (PAECs) were incubated with combinations of fresh or heat-inactivated human plasma, platelets, or monocytes, after which they were separated and analyzed individually by flow cytometry for tissue factor (TF) expression and for their ability to clot recalcified normal or factor-VII-deficient plasma.


RESULTS
Procoagulant porcine TF was induced in PAECs only by fresh human plasma, and not by heat-inactivated plasma, platelets, or monocytes. In contrast, procoagulant human TF was induced on platelets and monocytes after incubation with PAEC, irrespective of whether the plasma was present or not. In addition, human platelets caused the shedding of procoagulant TF-expressing aggregates from PAEC.


CONCLUSIONS
This work defines a cell-based in vitro assay system to address complex interactions among PAECs, human platelets, and monocytes. The induction of procoagulant TF on PAECs by fresh human plasma was most likely dependent on xenoreactive natural antibody and complement present in fresh human plasma. In contrast, the shedding of procoagulant platelet-PAEC aggregates, induced by human platelets, and the induction of procoagulant TF on human platelets and monocytes by PAEC, occurred independently of these factors. These results suggest that different mechanisms may contribute to the initiation of thrombosis after xenotransplantation, some of which may not be influenced by the further manipulation of the immune response against pig xenografts.
Lin
Chih Che
CC
Department of Immunology, Imperial College London, Hammersmith Hospital, London, United Kingdom.
Chen
Daxin
D
McVey
John H
JH
Cooper
David K C
DK
Dorling
Anthony
A
D000818:Animals; D000906:Antibodies / Q000276:immunology; D001011:Aorta; D017209:Apoptosis; D001777:Blood Coagulation; D001792:Blood Platelets / Q000502:physiology*; D004730:Endothelium, Vascular / Q000502:physiology*; D005434:Flow Cytometry; D016027:Heart Transplantation; D006801:Humans; D009000:Monocytes / Q000502:physiology*; D010215:Papio; D013552:Swine; D013925:Thromboplastin / Q000096:biosynthesis* / Q000276:immunology; D014183:Transplantation, Heterologous
D000906:Antibodies; D013925:Thromboplastin
Xenotransplantation. 2006 Jan;13(1):63-8
16497213
Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):1015-22
15117736
Cardiovasc Res. 2003 Oct 15;60(1):40-8
14522405
Transplantation. 2001 Dec 15;72(11):1858-61
11740405
Science. 2003 Jan 17;299(5605):411-4
12493821
Blood. 1997 Apr 1;89(7):2429-42
9116287
Transplantation. 2000 Feb 27;69(4):475-82
10708098
Annu Rev Med. 2002;53:133-47
11818467
Blood. 1997 Jan 15;89(2):541-9
9002957
Blood. 1990 Apr 1;75(7):1481-9
2317559
Ann Transplant. 2001;6(3):12-6
11899892
Circulation. 2005 Jul 12;112(2):248-56
15998670
Nat Med. 2003 Apr;9(4):458-62
12652293
J Exp Med. 2006 Oct 30;203(11):2433-40
17060476
Transplantation. 2004 Jun 15;77(11):1735-41
15201675
Circ Res. 2002 Dec 13;91(12):1135-41
12480814
J Clin Endocrinol Metab. 2005 Feb;90(2):1181-8
15562024
Am J Transplant. 2004 Dec;4(12):1958-63
15575897
Nat Med. 2005 Jan;11(1):29-31
15619628
J Immunol. 1993 Apr 1;150(7):2972-80
8095957
J Am Soc Nephrol. 2005 Sep;16(9):2732-45
16049072
Thromb Haemost. 1998 Mar;79(3):529-38
9531035
Transplant Proc. 2000 Aug;32(5):970
10936302
Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2311-5
10051638
Transplantation. 1993 Dec;56(6):1433-42
8279016
Nat Med. 2002 Oct;8(10):1175-81
12244306
Transplantation. 2007 Jul 15;84(1):1-7
17627227
J Thromb Haemost. 2007 Jun;5(6):1097-105
17567444
Thromb Haemost. 2001 Jul;86(1):66-74
11487043
Transplantation. 2005 Nov 27;80(10):1493-500
16340796
Transplantation. 2001 Aug 15;72(3):509-15
11502984